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Description: Ce travail de thèse évalue l'impact de la consommation importante d'alcool sur 
les facteurs de risque cardiovasculaire et l'estimation du risque cardiovasculaire à 10 ans 
(risque de développer une maladie coronarienne), dans une population avec une 
consommation moyenne élevée d'alcool. La consommation modérée d'alcool a été liée à un 
risque plus faible de développer une maladie coronarienne. Cependant, les données 
concernant la consommation importante d'alcool et le risque de développer une maladie 
coronarienne sont conflictuelles. Il y a également peu d'études dans lesquelles les 
consommations importantes d'alcool ont pu être évaluées en raison du petit nombre de sujets 
présentant une telle consommation. 
Résultats: Nous avons utilisé les données de l'étude CoLaus, une étude populationnelle qui 
inclut des adultes, âgés de 35 à 75 ans, de la ville de Lausanne. Nous avons inclus 5 '769 
participants, sans maladie cardiovasculaire, pour lesquels la consommation d'alcool d'une 
semaine a été catégorisée en 0, 1 à 6, 7 à 13, 14 à 20, 21 à 27, 28 à 34 et 2 35 verres/semaine 
et en non-consommateur (0 verre/semaine), consommateur modéré (1 à 13 verres/semaine), 
important (14 à 34 verres/semaine) et très important (2 35). La tension artérielle et les lipides 
ont été mesurés et le risque de développer une maladie coronarienne à 10 ans a été calculé en 
utilisant le score de Framingham. 73% des participants consommaient de l'alcool; 16% 
étaient des consommateurs importants et 2% des consommateurs très importants. L'analyse 
multivariée a montré une augmentation du cholestérol HDL avec la consommation d'alcool 
(de 1.57±0.01 [moyenne± erreur standard] chez les non consommateurs à 1.88±0.03 mmol/L 
chez les consommateurs très importants), des triglycérides (1.17±1.01 à 1.32±1.05 mmol/L) et 
des valeurs de tension artérielle systolique (127.4±0.4 à 132.2±1.4 mm Hg) et diastolique 
(78.7±0.3 à 81.7±0.9 mm Hg, toutes les valeurs de p pour trend<0.001). Quant au risque de 
développer une maladie coronarienne à 10 ans, il a augmenté de 4.31 %±0.10 à 4.90%±0.37 
(p=0.03) avec la consommation d'alcool, en décrivant une courbe en J. En examinant le type 
de consommation, on a vu que la consommation de vin a plus d'effet sur l'augmentation des 
valeurs de cholestérol HDL, alors que la consommation de bière ou de spiritueux a plus 
d'effet sur l'augmentation des valeurs de triglycérides. 
Conclusions et perspectives: Nos résultats montrent qu'en ce qui concerne l'estimation du 
risque cardiovasculaire à 10 ans, l'effet protecteur de la consommation d'alcool disparaît pour 
des consommations très importantes, car l'effet bénéfique des valeurs augmentées de 
cholestérol HDL est contrecarré par l'augmentation des valeurs de tension artérielle. Quant 
aux différents types d'alcool, d'autres études sont nécessaires pour mieux évaluer leur effet 
spécifique sur les facteurs de risque cardiovasculaire. 
Alcohol Drinking and Cardiovascular Risk in a Population With 
High Mean Alcohol Consumption 
Maryline Foerster, MDa, Pedro Marques-Vidal, MD, PhDa,b, Gerhard Gmel, PhDd,e, 
Jean-Bernard Daeppen, MDct, Jacques Cornuz, MD, MPHc, Daniel Hayoz, MDr, Alain Pécoud, MDC, 
Vincent Mooser, MD11, Gérard Waeber, MDg, Peter Vollenweider, MDg, Fred Paccaud, MDa, and 
Nicolas Rodondi, MD, MAsc·* 
Moderate alcohol consumption has been associated with lower coronary artery disease 
(CAD) risk. However, data on the CAD risk associated with high alcohol consumption are 
conflicting. The aim of this study was to examine the impact of heavier drinking on 10-year 
CAD risk in a population with high mean alcohol consumption. In a population-based 
study of 5,769 adults (aged 35 to 75 years) without cardiovascular disease in Switzerland; 
1-week alcohol consumption was categorized as 0, 1 to 6, 7 to 13, 14 to 20, 21 to 27, 28 to 
34, and ;:::35 drinks/week or as nondrinkers (0 drinks/week), moderate (1 to 13 drinks/ 
week), high (14 to 34 drinks/week), and very high (::::::35 drinks/week). Blood pressure and 
lipids were measured, and 10-year CAD risk was calculated according to the Framingham 
risk score. Seventy-three percent (n = 4,214) of the participants consumed alcohol; 16% 
(n = 909) were high drinkers and 2% (n = 119) very high drinkers. In multivariate analysis, 
increasing alcohol consumption was associated with higher high-density lipoprotein cho-
lesterol (from a mean ± SE of 1.57 ± 0.01 mmol/L in nondrinkers to 1.88 ± 0.03 minol/L 
in very high drinkers); triglycerides (1.17 ± 1.01 to 1.32 ± 1.05 mmol/L), and systolic and 
diastolic blood pressure (127.4 ± 0.4 to 132.2 ± 1.4 mm Hg and 78.7 ± 0.3 to 81.7 ± 0.9 
mm Hg, respectively) (ail p values for trend <0.001). Ten-year CAD risk increased from 
4.31 ± 0.10% to 4.90 ± 0.37% (p = 0.03) with alcohol use, with a J-shaped relation; 
Increasing. wine consumption was more related to high-density lipoprotein cholesterol 
levels, whereas beer and spirits were related to increased triglyceride levels. In conclusion, 
as measured by 10-year CAD risk, the protective effect of alcohol consumption disappears 
in very high drinkers, because the beneficial increase in high-density lipoprotein cholesterol is 
offset by the increases in blood pressure levels. © 2009 Elsevier Inc. (Am J Cardiol 2009;103: 
361-368) 
The aim of this study was to assess the impact of heavier 
drinking on lipids, blood pressure, high-sensitivity C-reac-
tive protein (hs-CRP), and 10-year coronary artery disease 
(CAD) risk in a population-based study in Switzerland in 
individuals with high mean alcohol consumption. 
Methods 
This cross-sectional study examined participants in the Co-
horte Lausannoise (CoLaus) study, a population-based study of 
alnstitute of Social and Preventive Medicine, bCARDIOMET, and "De-
partment of Ambulatory Care and Community Medicine, University of Lau-
sanne; a Alcohol Treatment Center, Lausanne University Hospital; eSwiss 
Institute for the Prevention of Alcohol and Drug Problems; Department of 
Medicine, Divisions of 1Vascular Medicine and glntemal Medicine, Centre 
Hospitalier Universitaire Vaudois, Lausanne, Switzerland; and hMedical Ge-
netics, GlaxoSmithKiine, Philadelphia, Pennsylvania. Manuscript reœived 
July 10, 2008; revised manuscript received and accepted September 12, 
2008. 
This study was supported by research grants from the Faculty of Biology 
and Medicine of Lausanne, Switzerland, and from GlaxoSmithKline, Phila-
delplùa, Pennsylvania. 
· *Corresponding author: Tel: 41-21-314-60-53; fax: 41-21-314-61-08. 
E-mail address: nicolas.rodondi@hospvd.ch (N. Rodondi). 
0002-9149/09/$ - see front matter © 2009 Elsevier lnc. 
doi: 10.1016/j.amjcard.2008.09 .089 
6, 187 Caucasian community-dwelling men and women aged 
35 to 75 years. Participants were selected from a random 
sample of all age-eligible adults living in the city of Lausanne, 
Switzerland (population 117,161). The details of eligibility 
criteria have been described previously.1 Ail participants gave 
written informed consent and the institutional review board in 
Lausanne approved the protocol. All participants were inter-
viewed and examined at the clinical center from summer 2003 
to spring 2006. 
We further excluded 411 participants with cardiovascu-
lar disease, defined as a self-reported diagnosis of CAD 
(angina, previous myocardial infarction, percutaneous cor-
onary angioplasty, or coronary artery bypass graft), stroke, 
or peripheral arterial disease. We also excluded 7 partici~ 
pants with missing variables for alcohol consumption. The 
final sample for our analysis was 5,769. 
Participants reported whether they currently consumed 
é(lcohol and how many standard drinks they had consumed 
in the past 7 days, i,1sing the same method as othèr studies.2'3 
A standard drink was defined as â glass of wine, a bottle of 
beer; or a shot of spifüs, approximating 10 to 12 g of 
ethanol.4•5 Subjects were then categorized according to the 
number of drinks per week: 0, 1 to 6, 7 to 13, 14 to 20, 21 
to 27, 28 to 34, and 2::35 drinks/week. An alternative 4-level 
www.AJConline.org 
Table 1 
Participant characteristics according to alcohol consumption of the previous 7 days (n = 5,769) 
Characteristic All Subjects Alcohol Use (Drinks in the Past Week) p Value 
0 1-6 7-13 14-20 21-27 28-34 ;:o:,35 
Il 1,555 2.051 1,135 567 241 101 119 
Age (yrs) 52.5 :!: 10.6 52.1 :!: 10.8 51.9 :!: 10.6 52.8 :!: 10.7 53.9 :!: 10.7 53.2 :!: 9.8 53.3 :!: 10.0 54.0 :!: 10.7 <0.001 
Women 3,076 (53%) 1,134 (73%) 1,237 (60%) 483 (43%) 151 (27%) 45 (19%) 13 (13%) 13 (11%) <0.001 
Physical activity (min/wk) 64.3 :!: 50.9 65.6 :!: 55.2 62.2 :!: 41.5 64.8 :!: 48.7 67.5 :!: 60.l 65.8 :!: 62.8 65.8 :!: 77.6 58.5 :!: 55.5 0.20 
Diabetes mellitus* 252 (4%) 84 (5%) 75 (4%) 46(4%) 21 (4%) 10 (4%) 8 (8%) 8 (7%) 0.06 
Hypertension 1· 2,035 (35%) 546 (35%) 622 (30%) 372 (33%) 246 (43%) 116 (48%) 56 (56%) 77 (65%) <0.001 
Body mass index (kg/m2) 25.7 :!: 4.5 26.5 :!: 0.1 25.4 :!: 0.1 25.3 :!: 0.1 25.2 :!: 0.2 25.5 :!: 0.3 25.8 :!: 0.4 25.8 :!: 0.4 <0.001 
Education (yrs) 13.1 :!: 4.3 12.l :!: 4.4 13.6 :!: 4.2 13.7 :!: 4.1 13.0 :!: 4.6 12.8 :!: 4.0 13.6 :!: 4.9 12.7 :!: 4.3 <0.001 
Smoking status <0.001 
Never 2,358 (41 %) 828 (53%) 901 (44%) 386 (34%) 156 (28%) 50 (21 %) 18 (18%) 19 (16%) 
Former 1,840 (32%) 388 (25%) 671 (33%) 420 (37%) 212 (37%) 76 (32%) 35 (35%) 38 (32%) 
Cunent 1,571 (27%) 339 (22%) 479 (23%) 329 (29%) 199 (35%) 115 (48%) 48 (48%) 62 (52%) 
Self-rep01ted alcohol consmnption 
Standard no. of drinks/wk 
Wine 6.9 :!: 7.1 2.7 :!: 1.7 6.9 :!: 2.8 12.0 :!: 4.5 15.3 :!: 6.2 20.8 :!: 8.0 28.9 :!: 15.2 <0.001 
Beer 1.9 :!: 4.4 0.5 :!: 1.0 1.4 :!: 2.2 3.0 :!: 4.2 5.3 :!: 6.1 7.2 :!: 7.7 13.6 :!: 13.6 <0.001 
Spilits or liquor 0.7 :!: 2.3 0.2 :!: 0.8 0.7 :!: 1.7 LO:!: 2.3 2.2 :!: 3.7 2.0 :!: 3.2 3.9 :!: 8.1 <0.001 
% of total consumption 
Wine 76.7 :!: 31.0 79.3 :!: 33.3 76.9 :!: 28.3 75.5 :!: 28.2 67.3 :!: 27.4 69.l :!: 26.6 62.7 :!: 28.5 <0.001 
Beer 15.9 :!: 26.2 13.5 ± 27.6 15.4 ± 22.8 18.l :!: 24.8 23.l :!: 26.5 24.2 :!: 25.9 29.0 :!: 27.5 <0.001 
Spirits or liquor 7.4 :!: 19.0 7.2 :!: 21.3 7.7 :!: 17.9 6.4 :!: 14.3 9.7 :!: 15.6 6.7 :!: 10.5 8.4 :!: 17.3 0.29 
Abnormal total CDT* 330 (6%) 12 (1 %) 30 (2%) 62 (6%) 77 (14%) 71 (31 %) 28 (28%) 50 (45%) <0.001 
Abnormal asialotransfo1Tin§ 92 (2%) 4 (0.3%) 5 (0.3%) 11 (1 %) 20 (4%) 21 (9%) 12 (12%) 19 (17%) <0.001 
Data are expressed as mean :!: SD or as number (percentage). Total percentages do not always exactly sum to 100% because of rounding. 
* Defined as self-reported medical diagnosis and/or use of any hypoglycemic medication.16 
t Defined as self-reported medical diagnosis and use of antihypertensive medication and/or measured systolic blood pressure ;:o:,140 mm Hg and/or diastolic blood pressure <'=90 mm Hg. 
* Expressed as a percentage of the total amount of serum transferrin and defined as abnormal if 2:1.63% according to the Central Laboratory of Lausanne University Hospital standards. 
§ Expressed as a percentage of the total amount of serum transferrin and defined as abnormal if >0%.8 
p Value 
for Trend 
0.02 
<0.001 
0.47 
0.10 
<0.001 
0.47 
0.53 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
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<0.001 
<0.001 
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Table 2 
Ten-year coronary artery disease risk. cardiovascular risk factors, and high-sensitivity C-reactive protein according to alcohol consumption in the previous 7 days (n = 5,769) 
Characte1istic Alcohol Use (D1inks in the Past Week) p Value by p Value for P1 P2 p3 
0 1-6 7-13 14-20 21-27 28-34 '.2:35 
ANOVA Trend Value* Value* Value* 
n 1.555 2.051 1,135 567 241 101 119 
10-year CAD lisk 3.13 ± 0.14 3.48 ± 0.12 4.69 ± 0.16 6.27 ± 0.23 7.39 ± 0.35 7.73 ± 0.55 8.52 ± 0.50 <0.001 <0.001 <0.001 <0.001 <0.001 
Systolic blood pressure 126.8 ± 0.4 125.3 ± 0.4 127.9 ± 0.5 133.3 ± 0.7 133.9 ± 1.1 135.5 ± 1.7 136.7 ± 1.6 <0.001 <0.001 0.26 <0.001 <0.001 
(mm Hg) 
Diastolic blood pressure 78.7 ± 0.3 78.2 ± 0.2 79.2 ± 0.3 82.0 ± 0.4 83.0 ± 0.7 84.4 ± 1.1 83.4 ± LO <0.001 <0.001 0.64 <0.001 <0.001 
(mm Hg) 
Total cholesterol (mmol/L) 5.55 ± 0.03 5.54 ± 0.02 5.63 ± 0.03 5.70 ± 0.04 5.87 ± 0.07 6.03 ± 0.10 5.93 ± 0.09 <0.001 <0.001 0.36 <0.001 <0.001 
HDL cholesterol (mmol/L) 1.63 ± 0.01 1.66 ± 0.01 1.65 ± 0.01 1.63 ± 0.02 1.60 ± 0.03 1.65 ± 0.04 1.66 ± 0.04 0.18 0.80 0.04 0.79 0.41 
LDL cholesterol (mmol/L)"~ 3.32 ± 0.02 3.30 ± 0.02 3.37 ± 0.03 3.42 ± 0.04 3.53 ± 0.06 3.61 ± 0.09 3.38 ± 0.09 <0.001 0.005 0.86 <0.001 0.54 
Triglycelides (mmol/L)* 1.14 ± 1.01 1.10 ± 1.01 1.19 ± 1.02 1.25 ± 1.02 1.44 ± 1.03 1.43 ± 1.05 1.60 ± 1.05 <0.001 <0.001 0.58 <0.001 <0.001 
Total cholesterol/HDL 3.62 ± 0.03 3.56 ± 0.03 3.64 ± 0.03 3.72 ± 0.05 3.93 ± 0.07 3.87 ± 0.11 3.88 ± 0.10 <0.001 <0.001 0.30 <0.001 0.02 
cholesterol 
hs-CRP (mg!L)*§ 
Women 1.58 ± 1.03 1.27 ± 1.03 1.17 ± 1.05 1.27 ± 1.10 1.31 ± 1.18 0.95 ± 1.37 0.94 ± 1.37 <0.001 0.08 <0.001 0.008 0.11 
Men 1.33 ± 1.05 1.07 ± 1.04 1.16 ± 1.04 1.49 ± 1.05 1.39 ± 1.08 1.55 ± 1.12 1.62 ± 1.11 <0.001 <0.001 0.002 0.14 0.09 
Data are expressed as mean ± SE. 
* NondJinkers and moderate, high, and very high alcohol consumption groups were defined according to previous research4•5: nondlinkers = 0 drinks/week, moderate = 1 to 13 dlinks/week, high = 14 
to 34 d1inks/week, and very high ('2=35 drinks/week); p1, comparing moderate drinkers with nondlinkers; p2 , comparing high dlinkers with nondJ·inkers; p3 , comparing very high drinkers with nondlinkers. 
t LDL cholesterol values were not calculated when tliglyce1ides were >4.5 rnmol/L. 
* T1iglyce1ides and hs-CRP levels were log transformed for statistical analysis because the distlibutions were skewed. 
§ The p value for interaction by gender was statistically significant for hs-CRP (p = 0.03) in the multivaliate mode!. 
ANOVA = analysis of variance. 
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Table 3 
Adjusted 10-year coronary artery disease iisk, cardiovascular 1isk factors, and high-sensitivity C-reactive protein according to alcohol consumption in the previous 7 days (n = 5,769) 
Characte1istic Alcohol Use (Drinks in the Past Week) p Value by p Value for P1 P2 p3 
0 1-6 7-13 14-20 21-27 28-34 2'35 
ANOVA Trend Value* Value* Value* 
n· 1.555 2.051 1.135 567 241 101 119 
10-year CAD risk 4.31 ± 0.10 4.19 ± 0.09 4.03 ± 0.12 4.25 ± 0.17 4.56 ± 0.26 4.60 ± 0.39 4.90 ± 0.37 <0.001 0.03 0.16 0.70 0.12 
Systolic blood pressure (mm 127.4 ± 0.4 126.4 ± 0.3 127.5 ± 0.4 130.9 ± 0.6 131.4 ± 1.0 132.7 ± 1.5 132.2 ± 1.4 <0.001 <0.001 0.16 <0.001 0.001 
Hg)t 
Diastolic blood pressure 78.7 ± 0.3 78.7 ± 0.2 79.2 ± 0.3 81.3 ± 0.4 82.2 ± 0.7 83.4 ± 1.0 81.7 ± 0.9 <0.001 <0.001 0.67 <0.001 0.002 
(mm Hg)t 
Total cholesterol (mmol!L)* 5.52 ± 0.03 5.56 ± 0.02 5.65 ± 0.03 5.69 ± 0.04 5.88 ± 0.06 6.04 ± 0.10 5.95 ± 0.09 <0.001 <0.001 0.03 <0.001 <0.001 
HDL cholesterol (mmol/L)* 1.57 ± 0.01 1.62 ± 0.01 1.67 ± 0.01 1.73 ± 0.02 1.76 ± 0.02 1.84 ± 0.04 1.88 ± 0.03 <0.001 <0.001 <0.001 <0.001 <0.001 
LDL cholesterol (mmol!L)*·§ 3.33 ± 0.02 3.34 ± 0.02 3.37 ± 0.03 3.35 ± 0.04 3.45 ± 0.06 3.52 ± 0.09 3.31 ± 0.08 <0.001 0.27 0.62 0.15 0.72 
Tliglyce1ides (mmol!L)*·ll 1.17 ± 1.01 1.15 ± 1.01 1.17 ± 1.01 1.16 ± 1.02 1.27 ± 1.03 1.24 ± 1.05 1.32 ± 1.05 <0.001 <0.001 0.31 0.44 0.01 
Total cholesterol/HDL 3.73 ± 0.03 3.67 ± 0.02 3.58 ± 0.03 3.48 ± 0.04 3.56 ± 0.07 3.46 ± 0.10 3.41 ± 0.09 <0.001 <0.001 0.003 <0.001 0.001 
cholesterol 
hs-CRP mg/IJjf 
Women 1.41 ± 1.03 1.35 ± 1.03 1.26 ± 1.05 1.36 ± 1.08 1.43 ± 1.16 0.98 ± 1.32 1.09 ± 1.32 <0.001 0.19 0.10 0.53 0.34 
Men 1.32 ± 1.05 1.14 ± 1.04 1.19 ± 1.04 1.42 ± 1.05 1.25 ± 1.07 1.40 ± 1.11 1.34 ± 1.10 <0.001 0.21 0.02 0.57 0.86 
Data are expressed as mean ± SE and were adjusted for age. gender, education. units of weekly physical activity. tobacco use, and BMI. 
* Nond1inkers and moderate, high, and very high alcobol consurription groups were defined according to previous research45: nonchinkers = 0 chinks/week, moderate = 1 to 13 dlinks/week, high = 14 
to 34 drinks/week, and very high (2'35 drinks/week); p1, campa.ring moderate drinkers with nondrinkers; p2• comparing high drinkers with nonch-inkers; p3, comparing very higb dlinkers with nond1inkers. 
t Blood pressure values were adjusted for age, gender, education, units of weekly physical activity, BMI, antihype1iensive medication, and tobacco use. 
* Lipid values were adjusted for age, gender, education, units of weekly physical activity, BML statins, and tobacco use. 
§ LDL cholesterol values were not calculated when triglyce1ides were >4.5 =ol!L. 
Il Triglyceride and bs-CRP levels were log transformed for statistical analysis because the distributions were skewed. 
~The p value for interaction by gender was statistically significant for hs-CRP (p = 0.03) in the multivariate mode!. 
BMI = body mass index. Other abbreviation as in Table 2. 
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classification was used: nondrinkers (0 drinks/week), mod-
erate (1 to 13 drinks/week), high (J 4 to 34 drinks/week), 
and very high (235 drinks/week) alcohol consumption.4·6 
Three different types of alcoholic beverages were consid-
ered in this study: wine, beer, and spirits.7 Self-reported 
alcohol consumption was partially validated by measuring 
the blood levels of carbohydrate-deficient transferrin (CDT; 
a combination of asialotransferrin and disialotransferrin). 
CDT separation was obtained by capillary electrophoresis 
on a P/ ACE 5510 System (Beckman Coulter Instruments, 
Nyon, Switzerland). Normal CDT was defined as <1.63%, 
a eut-off value that included the 97.5th percentile of the 
abstinent and of the "social drinker" populations (consump-
tion <30 g ethanol/day). Nonnal asialotransferrin was de-
fined as a level of 0%, because detectable values enable the 
identification of chronic and abusive alcohol consumption.8 
W e examined the relation between alcohol consumption and 
CDT and asialotransferrin. We did not exclude pariicipants 
with high CDT who reported no alcohol consumption, be-
cause the specificity of CDT is 92% for alcohol consump-
tion. 8 
According to their smoking histories, participants were 
classified as never, current, or fonner smokers (if they had 
stopped smoking). B!ood pressure and heari rate were mea-
sured by trained field investigators, 3 times in the left ann in 
the seated position, after 210 minutes of rest, using an 
Omron HEM-907 automated oscillometric sphygmoma-
nometer (Omron Matsusaka Company, Ltd., Kyoto, Japan), 
with an appropriately sized cuff. The second and third 
measurements were averaged to reduce variability, as rec-
ommended.9 Hypertension was defined as self-report and 
the use of antihypertensive medications and/or measured 
systolic blood pressure 2140 mm Hg and/ or diastolic blood 
pressure 290 mm Hg. Total and high-density lipoprotein 
(HDL) cholesterol were measured after overnight fasting by 
enzymatic methods (cholesterol oxidase; Roche Diagnostics 
GmbH, Mannheim, Gennany). Low-density lipoprotein 
(LDL) cholesterol was calculated by the Friedewald equa-
tion. Triglycerides were assessed by glycerol phosphate 
oxidase-p-aminophenazone. Glucose was measured by glu-
cose dehydrogenase. Hs-CRP was assessed by immunoas-
say (HS Latex; Diagnostic Products Corporation, Los An-
geles, Califomia). Most biologie assays were perfonned by 
the Central Laboratory of Lausanne University Hospital, 
which is regularly checked for pe1fo1mance and quality. As 
in other studies,10 we calculated 10-year CAD risk for each 
participant using the Framingham risk score. 11 This version 
of the Framingham risk score includes diabetes mellitus and 
estimates the risk for CAD (angina pectoris, recognized and 
unrecognized myocardial infarction, coronary insufficiency, 
and CAD death). The Framingham risk score has the best 
prospective validation in several American 12 and interna-
tional 13 cohorts. In this version of the Framingham risk 
score, diabetes was defined as fasting blood glucose level 
27.8 mmol/L or receiving antidiabetic treatment. 
Self-reported level of education was used as a proxy for 
socioeconomic status, a validated proxy measure in Swit-
zerland.14 Physical activity was assessed by questions fo-
cusing on walking and other types of exercises in minutes 
per week. Weight was measured in kilograms with 0.1 kg 
precision using a Seca scale (Seca, Reinach, Switzerland) 
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Figure 1. Association between alcohol consumption, cardiovascular risk 
factors, and 10-year CAD risk. HDL cholesterol, systolic blood pressure 
(BP), and 10-year CAD 1isk according to last week alcohol consumption. 
Values are adjusted for age, gender, education, units of weekly physical 
activity, tobacco use, body mass index, statins (for HDL cholesterol), and 
antihypertensive medications (for systolic BP). Alcohol consumption was 
associated with increased HDL cholesterol (p for trend <0.001), systolic 
BP (p for trend <0.001), and 10-year CAD risk (p for trend = 0.03). 
that was regularly calibrated. Height was measured using a 
Seca height gauge with a precision of 0.5 cm. 
Statistical analyses were conducted using Stata version 
9.2 (StataCorp LP, College Station, Texas). Results are 
reported as mean ± SE or as numbers and percentages of 
subjects. A p value <0.05 was considered to represent 
statistical significance. Linear regression models were used 
to assess the unadjusted associations between alcohol cate-
gories and blood pressure, lipids, hs-CRP, and 10-year CAD 
risk. To assess other factors independently associated with 
alcohol consumption, the multivariate models further in-
cluded potential confounders identified by comparing base-
line characteristics across alcohol use categories: age, gen-
der, education, tobacco use, and body mass index, as in 
other studies.15 Antihypertensive medications and statins 
were also included as confounders for blood pressure and 
lipid levels, respectively. Physical activity was also in-
cluded as a potential confounder on the basis of clinical 
plausibility, despite a lack of significant differences. We 
used chi-square tests for trend for categorical variables and 
tests for trend for continuous variables across alcohol use 
categories.5 Because a significant gender-by-alcohol inter-
action was found for hs-CRP (p for interaction = 0.03), the 
results for hs-CRP were stratified by gender. A gender-by-
alcohol interaction was also found for LDL cholesterol (p = 
0.03), but no gender stratification was performed because no 
significant gender-by-alcohol interactions were found for 
other lipid values. The effects of the type of alcoholic 
beverage on cardiovascular risk factors, 10-year CAD risk, 
and hs-CRP were assessed, generating 3 variables, wine, 
beer, and spirits, corresponding to their consumption in 
drinks per week. If no drink was consumed, the variable was 
set to O. The 3 variables for the type of alcoholic beverage 
were used simultaneously in a multivariate model testing 
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Table 4 
Adjusted 10-year coronary artcry diseuse risk, cardiovascular risk factors, and high sensitivity C-reactive protein according to beverage type 
consumption in the previous 7 days 
Variable Wine Beer Spùits p Value* 
10-year CAD risk 0.01 ± 0.01 0.00 ± 0.01 0.02 ± 0.01 0.64 
Blood pressure (mm Hg)t 
Systolic 0.05 ± 0.02* 0.07 ± 0.02§ 0.01 ± 0.01 0.04 
Diastolic 0.08 ± 0.02• 0.06 ± 0.02§ 0.00 ± 0.02 0.001 
Lipids (mrnol/L)ll 
Total cholesterol 0.10 ± 0.02§ 0.06 ± 0.02* 0.02 ± 0.02 0.02 
HDL cholesterol 0.18 ± 0.02§ 0.05 ± 0.02* 0.01±0.01 <0.001 
LDL cholesterol11 0.02 ± 0.02 0.00 ± 0.02 0.00 ± 0.02 0.71 
Triglycerides# -0.01±0.02 0.07 ± 0.02• 0.04 ± 0.02** <0.005 
hs-CRP (mg/L)# 
Women -0:05 ± 0.02** 0.00 ± 0.02 0.02 ± 0.02 0.08 
Men -0.03 ± 0.02 0.04 ± 0.02 0.02 ± 0.02 0.10 
Data are expressed as standardized slopes per drink consumed per week ± SE7 and were adjusted for age, gender, education, units of weekly physical 
activity, tobacco use, and BMI. Only participants with alcohol consumption °27 drinks/week were included in this analysis. 
* Test for the hornogeneity of slopes (wine = beer = spirits). 
t Blood pressure values were adjusted for age, gender, education, units of weekly physical activity, BMI, antihypertensive rnedication, and tobacco use. 
t p <0.01. . 
§ p <0.001. 
Il Lipid values were adjusted for age, gender, education, units of weekly physical activity, BMI, statins, and tobacco use. 
11 LDL cholesterol vaines were not calculated when lriglycerides were >4.5 mrnol/L. 
# Triglyceride and hs-CRP Jevels were log transformed for statistical analysis because the distributions were skewed. 
**p <0.05. 
Abbreviations as in Tables 2 and 3. 
the hypothesis of the equality of the different standardized 
regression coefficients for each beverage type.7 The stan-
dardized regression coefficients represent the change in the 
dependent variables that resulted from a change of 1 SD in 
each of the independent variables. 
Results 
The baseline characteristics of the participants are listed 
in Table 1. About three quarters of the participants (73%) 
consumed alcohol, and more than half (55%) had moderate 
consumption (1 to 13 drinks/week); 16% had high con-
sumption (14 to 34 drinks/week), and 2% had very high 
consumption (~35 drinks/week). Wine was the most fre-
quent beverage type consumed, and beer consumption was 
predominant in men. Women were less likely to be in the 
high or very high alcohol consumption groups and, overall, 
tended to drink less alcohol than men. Higher alcohol con-
sumption was associated with increased levels of CDT and 
asialotransferrin, tobacco smoking, and hyperiension (all p 
values for trend <0.001). 
In unadjusted analysis (Table 2), increasing alcohol use 
was associated with increasing systolic and diastolic blood 
pressure, total cholesterol, the ratio of total to HDL choles-
terol, LDL cholesterol, triglycerides, and 10-year CAD risk. 
A significant positive relation between alcohol use and 
hs-CRP was also found in men, but not in women (inverse 
nonsignificant trend). No significant relation was found be-
tween alcohol consumption and HDL cholesterol level. 
In multivariate analysis, alcohol consumption was asso-
ciated with increased systolic and diastolic blood pressure, 
total and HDL cholesterol, the ratio of total to HDL cho-
lesterol, triglycerides, and 10-year CAD risk (Table 3). 
Conversely, no significant trend was found for LDL cho-
lesterol levels, nor for hs-CRP levels, but only in men. In 
women, hs-CRP was inversely associated with alcohol con-
sumption, although the levels observed in the 2 highest 
consumption groups should be interpreted with caution be-
cause of the small numbers (Table 1). Restricting the anal-
ysis to nonsmoking participants provided similar results 
(not shown). The confounding factors responsible for the 
changes in the relation between alcohol consumption and 
cardiovascular risk factors were as follows: for HDL cho-
lesterol, body mass index, physical activity and smoking; 
for LDL cholesterol, gender and age; and for hs-CRP, body 
mass index in women and smoldng (major effect) and age in 
men. The association between alcohol consumption and 
10-year CAD risk and systolic blood pressure showed a 
J-shaped relation (Figure 1), while the levels of HDL cho-
lesterol increased monotonically with the level of alcohol 
consumption. Excluding subjects with diabetes led to sim-
ilar results. Removing from the multivariate model tobacco 
use (which is used in the Framingham risk score) yielded a 
similar pattern of association between alcohol consumption 
and 10-year CAD risk. 
The effects of wine, beer, and spirits on each cardiovas-
cular risk factor and 10-year CAD risk were assessed by 
multivariate analysis separately for each beverage type (Ta-
ble 4). The standardized regression slopes coITespond to the 
variation in cardiovascular risk factors, 10-year CAD risk, 
or hs-CRP for 1 additional drink per week for each beverage 
type. The relation between alcohol and 10-year CAD risk 
score did not differ by beverage type. For HDL cholesterol, 
increased consumption of wine had a stronger effect than 
that of beer, and spirits had no effect. Similarly, wine and 
beer but not spirits had an impact on blood pressure and 
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total cholesterol (all p values of equality of slopes <0.04). 
The level of triglycerides increased with beer or spirits 
consumption but not with wine. No statistically significant 
differences regarding the effects of each type of alcoholic 
beverage were found for other factors. 
Discussion 
In this population-based study including a substantial 
propo11ion of high drinkers, increasing alcohol consumption 
was associated with higher HDL cholesterol levels but also 
with increased levels of total cholesterol and triglycerides 
and increased blood pressure values, resulting in a J-shaped 
relation with 10-year CAD risk. TI1e protective effect of 
alcohol on CAD risk disappears because the increase in 
blood pressure offsets the benefits of the increase in HDL 
cholesterol. 
A previous cross-sectional study conducted in women in 
the United Kingdom5 found a linear decrease in 10-year 
CAD risk with average alcohol consumption up to 21 
drinks/week but could not examine the effects of higher 
amounts because of the very smail number of participants 
reporting higher consumption. A study that pooled cohort 
studies conducted in Denmark 17 showed a lower risk for 
death from CAD with increasing alcohol consurnption, al-
though the effects were different according to beverage 
type: beyond 21 drinks/week, a further decrease of CAD 
risk was found only for wine, but higher consumption was 
not further stratified. The Danish study also showed that 
wine drinkers had lower mortality from both CAD and 
cancer than nonwine drinkers. The discrepancy between our 
results and those from the United Kingdom5 and Denmark17 
for wine drinkers might be explained by the wider range of 
alcohol consumption (through 35 drinks/week) included in 
our study: more subjects were consequently classified as 
heavy drinkers (i.e., more subjects had high CAD risk). In 
Denrnark (as in other northern European countries); these 
results might also partially be related to the different (and 
probably healthier) lifestyle of the wine drinkers. 18 
In the present study, we found that the J-shaped relation 
between increasing alcohol consumption and 10-year CAD 
risk was most likely related to the moving balance of the 
effects of alcohol consurnption. The main mechanism is 
related to HDL cholesterol and blood pressure: as alcohol 
consumption increases, the protective effect of an increas-
ing HDL cholesterol level is progressively outweighed by 
the deleterious effect of increased blood pressure levels. A 
previous prospective cohort study conducted in Scottish 
men2 suggested that the high CAD mortality in heavy dtink-
ers (> 15 dtinks/week) was related to the effect of blood 
pressure. 
The increase in HDL cholesterol level with total alcohol 
consumption has bee~ previously described7•19 and is pre-
sumed to be the main mechanism for the protective effect of 
moderate alcohol consumption on CAD. 19 In this study, 
increasing wine consumption was more related to increased 
HDL cholesterol level. The direct link between wine and 
HDL cholesterol level is in agreement with some studies7•20 
but not with others.21 Possible main confounders include the 
higher socioeconomic status or the healthier behaviors of 
wine drinkers21 or the fact that the major beverage type 
consumed by a population, wine in this population, has 
often been shown to have the strongest and most significant 
association with cardiovascular risk factors. 22 
In the present data, alcohol consumption was positively 
related to triglyceride levels, in agreement with some stud-
ies23 but not with others.5•20 Multivariate analysis showed 
no effect of wine on triglycerides but did show effects of 
spirits and beer, similar to previous studies.7·21 However, 
residual confounding due to incomplete adjustment cannot 
be ruled out, and further studies are needed to better assess 
the specific effects of beverage types on triglyceride levels. 
The direct association between the level of alcohol con-
sumption and blood pressure is in agreement with previous 
research,7 ·20 and this study provides additional information 
on the effect of high levels of alcohol consumption. 
Whether the type of alcoholic beverage matters is still 
debated.7•24 In the present study, wine and beer exerted 
similar effects on blood pressure. 
In the present data, an inverse relation between alcohol 
consumption and hs-CRP levels was found in women, albeit 
not statistically significant, whereas a more complex J-
shaped relation was found in men. The decrease in hs-CRP 
levels with increased alcohol consumption in women is in 
agreement with previous studies, whereas the lack of de-
crease in male alcohol drinkers does not reproduce previous 
reports,25 ·26 which might be related to the highest consump-
tion groups in our population. Indeed, in previous studies,25 
the inverse relation between alcohol consumption and hs-
CRP levels was found in drinkers of 1 to 7 drinks/week, 
whereas an increase in hs-CRP levels was found for higher 
levels of consumption. Overall, our data suggest that the 
beneficial effect of alcohol consumption on hs-CRP levels 
might actually disappear and become deleterious for levels 
of consumption >2 drinks/day. We found no major effect of 
beverage type, in agreement with a study in Chile.27 
Our study had several limitations. First, alcohol con-
sumption was self-reported, which might lead to the selec-
tive misclassification of heavy drinkers. However, data on 
alcohol consumption from food-frequency questionnaires 
and 1-week diet records have been shown to be well corre-
lated,28 and most studies on alcohol consumption have re-
lied on self-reported data. 2•7 Moreover, the present study 
used CDT levels to help validate reported alcohol consump-
tion. The use of a recall period limited to 1 week before the 
survey interview might also lead to the misclassification of 
some participants who do consume alcohol but who did not 
drink in the previous 7 days. Although this may artificially 
increase the propmtion of abstainers, short recall periods 
have been consistently shown to be better than long periods 
to assess consumption at higher levels.29 Another limitation 
is that our study did not capture drinking patterns, such as 
binge drinking. Finally, the 10-year CAD risk did not ac-
count for other potential beneficial effects of alcohol on 
variables that are not included in the Framingham dsk score, 
such as fibrinogen. 30 
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